phew rais pt
phew sit room yesterday adcom could help
remind icon marc cohn song walk
memphi great song opinion lost eric clapton
tear heaven song year year perhap
famou line song goe christian child
said tonight point vote
yesterday seem us virtual manag
team found religion never rememb mani collect
hand clasp togeth seek divin intervent end
day whatev manag did/prayed/hop work
overwhelm vote panel support ali refractori
ntm patient mark begin end good way
believ expect compani confer
call may well last believ like
acquir believ ali fit well within pipelin number
larger compani posit guess potenti
acquir might would say particular order astrazeneca
azn rate teva teva rate gilead rate
vertex neutral rate light adcom recommend
adjust po refractori ntm popul shift
price target reiter buy rate
continu next page
definit distribut analyst rate analyst certif disclosur pleas refer page report
remov mycobacterium patient burden matter physician today adcom panel vote
strongli favor approv ali refractori ntm patient end day panel comment clariti
cultur convers primari endpoint observ phase studi turn patient cultur neg signific
improv factor care ntm patient note state previou note august
treatment paradigm without increas safeti concern argument approv panel
safeti profil complex predominantli respiratori mild moder sever thu view accept
especi context seriou advers event associ current treatment regimen overwhelm perspect
member vote favor ali high unmet need indic proven altern note
median length time patient enter studi standard care four year prior studi thu
patient truli refractori patient demonstr cultur convers patient remov
long-term fail antibiot treatment also import note panel made decis predomin base
data primari endpoint secondari endpoint signific actual even trend
opinion confirm need new medic ntm one kol state newli approv agent
ntm nearli decad anoth opin happen backdrop increas rate ntm occurr
nearli per annum state previous evid favor cultur convers strike three separ
studi cultur convers approach ali treat approxim non-treat moreov ask
vote possibl use ali front-lin therapi panel equal clear discern con vote
favor evid treat patient refractori discuss need
question caus greatest concern question relat cultur convers clinic efficaci
cultur convers reason predict clinic efficaci perhap question call
surrog endpoint reflect either case convers relat reliabl endpoint reflect long-term benefit
patient opinion regul present seri data point lack difficulti translat durabl studi
open-label studi seri histor manuscript left panel dubiou posit confus
regard predict cultur convers applic well mani speaker commun open
session simpli state remov mycobacteri load patient signific benefit lead long-term clinic
benefit even clearli observ trial ultim panel agre narrowli applic vote
favor predict vote complex issu note signific ali
background therapi signific differ note cultur convert
even take account convert may predisposit allow improv
studi discount observ mycobacteri erad lead meaning improv
fatigu one main symptomat concern patient group moreov although data set may bias
control untreat group present studi data clearli show strong effect durat treatment
effect patient given ali specif patient complet month ali remain convert
background therapi abl sustain convers month later believ durabl effect
indic clinic efficaci respit patient continu fail medic year
thought reflect adcom end result win ali day progress
result complet appar discuss predict cultur convers clinic efficaci could
help think comparison orkambi vertex neutral respect adcom process vertex shown
surrog endpoint sweat chlorid improv significantli fair realli caus
level excit kalydeco vertex engend previous fact believ abil orkambi
also demonstr improv well decreas pulmonari exacerb carri day vertex
show small surrog endpoint translat clinic relev outcom think critic learn
ntm cf field new medic emerg higher bar cross approv thu
key element clinic efficaci import regul may actual focu measur
current approv surrog endpoint second import realiz respect variou regulatori approv
fast-track qualifi infecti diseas product qidp breakthrough statu opinion seen
mani drug compani artifici elev statu due receiv stand regul
notic situat ali realli matter statu approv receiv rather
data show efficaci result alway hold day would counsel hold applaus clear demonstr
safeti efficaci demonstr
valuat risk price target base multipl tax dilut
gaap ep discount back cat npv discount rate growth rate
risk invest thesi target price includ failur ali secur regulatori approv failur ali
achiev peak commerci revenu estim model due market size penetr rate and/or price
except per share valu
revenu
revenu
revenu
sale asset net
accret benefici convers charg
except patient number
probabl success ntm us trial
probabl success ntm eu ema
probabl success cf eu ema
patient refractori diseas
number patient refractori diseas
arikayc penetr refractori diseas
number refractori patient receiv arikayc
average annual arikayc us
patient refractori diseas
number patient refractori diseas
arikayc penetr refractori diseas
number refractori patient receiv arikayc
average annual arikayc eu ntm
project mm
chang work capit
materi confidenti intend use institut account defin finra rule may also
privileg otherwis protect work product immun legal rule receiv mistak pleas let
us know email repli delet system may copi messag
disclos content anyon integr secur messag guarante internet
 wainwright co llc rate wainwright employ three tier rate system evalu
potenti return risk associ own common equiti share rate firm expect return given
equiti measur rel basi compani sector price object calcul estim
potenti movement price given equiti could reach provid certain target met defin time horizon
price object subject extern factor includ industri event market volatil
market outperform buy common stock compani expect outperform passiv index compris
common stock compani within sector
market perform neutral common stock compani expect mimic perform passiv index
compris common stock compani within sector
market under-perform sell common stock compani expect under-perform passiv index compris
common stock compani within sector
rate price target histori insm incorpor insm-u
rate price target histori inc vrtx-u
relat compani mention report
invest bank servic includ limit act manager/co-manag underwrit placement
secur act financi advisor and/or provid corpor financ capit markets-rel servic compani
one affili subsidiari within past month
distribut rate tabl august
 wainwright co llc firm member finra sipc regist broker-deal
andrew fein li wang watsek alicia yin ph certifi view express report accur
reflect person view subject secur issuer discuss part compens
directli indirectli relat specif recommend view express research report neither
member household offic director advisori board member compani
none research analyst research analyst household financi interest secur insm
incorpor inc includ without limit option right warrant futur long short
juli neither firm affili benefici class common equiti secur
insm incorpor
neither research analyst firm materi conflict interest research analyst know
reason know time public research report
research analyst princip respons prepar report receiv compens base upon
specif invest bank servic transact compens base factor includ total revenu profit
firm substanti portion deriv invest bank servic
firm affili receiv compens insm incorpor inc invest
bank servic within twelv month seek compens compani mention report
invest bank servic within three month follow public research report
firm make market incorpor inc date research report
secur compani discuss report may unsuit investor depend specif invest
object financi posit past perform guarante futur result report offer inform
purpos constitut offer solicit buy sell secur discuss herein jurisdict
would prohibit research report intend provid tax advic use provid tax advic
person electron version wainwright co llc research report made avail client simultan
part report may reproduc form without express permiss wainwright co llc addit
 wainwright co llc provid individu tailor invest advic research report research report
intend provid person invest advic take account specif invest object financi
situat particular need specif person investor seek financi advic regard appropri
invest financi instrument implement invest strategi discuss recommend research report
 wainwright co llc affili salespeopl trader profession may provid oral written market
commentari trade strategi reflect opinion contrari opinion express research report
 wainwright co llc affili offic director employe exclud analyst time time
long short posit act princip buy sell secur deriv includ option warrant
thereof cover compani refer research report
inform contain herein base sourc believ reliabl guarante us
accur purport complet statement summari avail data compani industri secur
discuss report opinion estim includ report constitut analyst judgment date
report subject chang without notic
secur financi instrument discuss research report may lose valu insur feder
deposit insur corpor subject invest risk includ possibl loss princip amount invest
